Cell Ready, LLC completed the acquisition of Certain Cell Manufacturing Assets of Marker Therapeutics, Inc.
Cell Ready, LLC completed the acquisition of Certain Cell Manufacturing Assets from Marker Therapeutics, Inc. on June 26, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.25 USD | +4.94% | -3.41% | -22.73% |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-22.73% | 36.1M | |
+2.17% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+7.63% | 24.63B | |
-21.12% | 18.2B | |
+30.66% | 12.01B | |
-0.03% | 11.76B | |
+16.09% | 10.4B | |
-3.51% | 9.94B |